FDA Revises Recommendations Regarding Electronic Systems : v

Food and Drug Administration FDA issued updated draft guidance, Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations–Questions and Answers. Draft Guidance revamps earlier recommendations from 2017 regarding requirements of 21 CFR Part 11.

Related Keywords

Paul Clowes , Drug Administration , Advances In Technology , Digital Health Technologies Dhts , Information Technology Service Providers Itsps , Electronic Systems , Electronic Records , Electronic Signatures , Clinical Investigations , Draft Guidance , Technology Service Providers , Health Technologies , Based Approach , Docket Number , Clinical Investigations Under , Computerized Systems Used , Legal , Business , Fda , Ood And Drug Law , Hada Law , Food And Drug Administration , 21 Cfr Part 11 ,